Search

everythinglearnresearchcommunity

for

Search:↓

The ovary mainly causes high testosterone in PCO, while the adrenal gland is the main source in IH.

Dihydrotestosterone (DHT) and its active metabolites play a key role in various diseases, and the development of 5α-reductase inhibitors can help treat these conditions.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Clinical features of hyperandrogenism do not predict the success of conventional acne treatment in women.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

DHT deficiency may disrupt rat epididymis function by affecting estrogen receptors.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Antiandrogens help treat hormone-related conditions in both men and women.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Nuclear AR levels give better insight into hormone effects in skin conditions.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Gene mutations can cause problems in male genital development.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

The normalized androgen ratio can help manage conditions with excess androgen activity in women.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

New compounds may soon be tested to treat excessive hair growth in women.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Biotin can interfere with lab tests, causing misdiagnosis.

Dihydrotestosterone gel before hypospadias surgery led to less scarring but raised concerns about potential psychological effects and skin changes.

Genetic response to androgens is key in female pattern baldness, not SHBG levels.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Androgens can both increase body hair and cause scalp hair loss.

Men might have a version of the female disease, polycystic ovarian syndrome, shown by changes in hormone levels and early baldness, but more research is needed to fully understand it.

Mouse hair cells respond to male hormones by growing less, and this can be stopped by certain blockers.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The study created a new method to test drugs that affect hormone processing in skin.